Ray Lin

1.7k total citations
27 papers, 613 citations indexed

About

Ray Lin is a scholar working on Oncology, Statistics and Probability and Molecular Biology. According to data from OpenAlex, Ray Lin has authored 27 papers receiving a total of 613 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 8 papers in Statistics and Probability and 4 papers in Molecular Biology. Recurrent topics in Ray Lin's work include Statistical Methods in Clinical Trials (7 papers), Statistical Methods and Inference (5 papers) and Advanced Causal Inference Techniques (5 papers). Ray Lin is often cited by papers focused on Statistical Methods in Clinical Trials (7 papers), Statistical Methods and Inference (5 papers) and Advanced Causal Inference Techniques (5 papers). Ray Lin collaborates with scholars based in United States, Switzerland and Taiwan. Ray Lin's co-authors include Larry Léon, John F. Hurdle, James M. Slater, Susan D. Horn, Alexander S. Goldfarb‐Rumyantzev, Jerry D. Slater, Rosemary A. Schaefer, Eugen B. Hug, Daniel W. Miller and Sylvia K. Plevritis and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Scientific Reports.

In The Last Decade

Ray Lin

25 papers receiving 591 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ray Lin United States 11 280 272 123 73 64 27 613
Hongkun Wang United States 16 186 0.7× 132 0.5× 116 0.9× 51 0.7× 31 0.5× 61 588
Akihiro Hirakawa Japan 19 486 1.7× 278 1.0× 127 1.0× 147 2.0× 63 1.0× 60 1.0k
Martin Jenkins United Kingdom 16 150 0.5× 409 1.5× 207 1.7× 192 2.6× 23 0.4× 54 956
Jianchang Lin United States 18 395 1.4× 359 1.3× 293 2.4× 276 3.8× 53 0.8× 84 1.0k
Christophe Meille Switzerland 15 346 1.2× 88 0.3× 244 2.0× 31 0.4× 44 0.7× 30 682
Susan J. Robertson Canada 20 158 0.6× 673 2.5× 309 2.5× 43 0.6× 38 0.6× 42 1.3k
Gwynn Ison United States 9 216 0.8× 90 0.3× 65 0.5× 71 1.0× 35 0.5× 16 439
Joyce Cheng United States 13 596 2.1× 370 1.4× 244 2.0× 52 0.7× 66 1.0× 31 943
Aracelis Z. Torres United States 14 510 1.8× 388 1.4× 91 0.7× 87 1.2× 17 0.3× 34 826
Nadia Terranova Germany 14 131 0.5× 58 0.2× 135 1.1× 98 1.3× 28 0.4× 35 531

Countries citing papers authored by Ray Lin

Since Specialization
Citations

This map shows the geographic impact of Ray Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ray Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ray Lin more than expected).

Fields of papers citing papers by Ray Lin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ray Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ray Lin. The network helps show where Ray Lin may publish in the future.

Co-authorship network of co-authors of Ray Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Ray Lin. A scholar is included among the top collaborators of Ray Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ray Lin. Ray Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Rufibach, Kaspar, et al.. (2025). Balancing Events, Not Patients, Maximizes Power of the Logrank Test: And Other Insights on Unequal Randomization in Survival Trials. Statistics in Medicine. 44(10-12). e70101–e70101.
3.
Lin, Ray, Pralay Mukhopadhyay, Satrajit Roychoudhury, et al.. (2023). Comment on “Non-Proportional Hazards – an Evaluation of the MaxCombo Test in Cancer Clinical Trials” by the Cross-Pharma Non-Proportional Hazards Working Group. Statistics in Biopharmaceutical Research. 15(2). 312–314. 1 indexed citations
4.
Botta, Gregory P., et al.. (2022). Neoadjuvant chemotherapy and radiotherapy outcomes in borderline‐resectable and locally‐advanced pancreatic cancer patients. Cancer Medicine. 12(7). 7713–7723. 6 indexed citations
5.
Incerti, Devin, Michael T. Bretscher, Ray Lin, & Chris Harbron. (2022). A meta‐analytic framework to adjust for bias in external control studies. Pharmaceutical Statistics. 22(1). 162–180. 2 indexed citations
6.
Bao, Fei, et al.. (2021). Tri-modal management of primary small cell carcinoma of the pancreas (SCCP): a rare neuroendocrine carcinoma (NEC). BMC Gastroenterology. 21(1). 340–340. 3 indexed citations
7.
Du, Emma, et al.. (2021). Checkpoint Inhibition in the Treatment of Unresectable, Advanced Lymphoepithelioma-like Hepatocellular Carcinoma. Journal of Clinical and Translational Hepatology. 0(0). 0–0. 9 indexed citations
8.
Lin, Ray, Ji Lin, Satrajit Roychoudhury, et al.. (2020). Alternative Analysis Methods for Time to Event Endpoints Under Nonproportional Hazards: A Comparative Analysis. Figshare. 30 indexed citations
9.
Léon, Larry, Ray Lin, & Keaven M. Anderson. (2020). On Weighted Log-Rank Combination Tests and Companion Cox Model Estimators. Statistics in Biosciences. 12(2). 225–245. 8 indexed citations
10.
Jotte, Robert M., Federico Cappuzzo, Ihor Vynnychenko, et al.. (2018). IMpower131: Primary PFS and safety analysis of a randomized phase III study of atezolizumab + carboplatin + paclitaxel or nab-paclitaxel vs carboplatin + nab-paclitaxel as 1L therapy in advanced squamous NSCLC.. Journal of Clinical Oncology. 36(18_suppl). LBA9000–LBA9000. 170 indexed citations
11.
Juric, Dejan, Ian E. Krop, Ramesh K. Ramanathan, et al.. (2017). Phase I Dose-Escalation Study of Taselisib, an Oral PI3K Inhibitor, in Patients with Advanced Solid Tumors. Cancer Discovery. 7(7). 704–715. 120 indexed citations
12.
Lin, Ray & Larry Léon. (2017). Estimation of treatment effects in weighted log-rank tests. Contemporary Clinical Trials Communications. 8. 147–155. 29 indexed citations
13.
Lin, Ray, Tyng‐Guey Wang, Jau‐Yih Tsauo, et al.. (2015). Novel Noxipoint Therapy versus Conventional Physical Therapy for Chronic Neck and Shoulder Pain: Multicentre Randomised Controlled Trials. Scientific Reports. 5(1). 16342–16342. 6 indexed citations
14.
Hao, Zhonglin, Ramses Sadek, Lisa J. Marshall, et al.. (2015). 346 Phase 1a study of the safety, pharmacokinetics, and pharmacodynamics of GDC-0919 in patients with recurrent/advanced solid tumors. European Journal of Cancer. 51. S69–S69. 14 indexed citations
15.
Lin, Ray & Sylvia K. Plevritis. (2011). Comparing the benefits of screening for breast cancer and lung cancer using a novel natural history model. Cancer Causes & Control. 23(1). 175–185. 24 indexed citations
16.
Lin, Ray, Susan D. Horn, John F. Hurdle, & Alexander S. Goldfarb‐Rumyantzev. (2008). Single and multiple time-point prediction models in kidney transplant outcomes. Journal of Biomedical Informatics. 41(6). 944–952. 48 indexed citations
17.
Lu, Wen‐Hsiang, et al.. (2007). Using Web resources to construct multilingual medical thesaurus for cross-language medical information retrieval. Decision Support Systems. 45(3). 585–595. 10 indexed citations
18.
Lin, Ray, et al.. (2006). Overcoming terminology barrier using Web resources for cross-language medical information retrieval.. PubMed. 519–23. 6 indexed citations
19.
Lin, Ray, Soo‐Yon Rhee, Robert W. Shafer, & Amar K. Das. (2006). A COMBINED DATA MINING APPROACH FOR INFREQUENT EVENTS: ANALYZING HIV MUTATION CHANGES BASED ON TREATMENT HISTORY. PubMed. 385–388. 5 indexed citations
20.
Lin, Ray, Eugen B. Hug, Rosemary A. Schaefer, et al.. (2000). Conformal proton radiation therapy of the posterior fossa: a study comparing protons with three-dimensional planned photons in limiting dose to auditory structures. International Journal of Radiation Oncology*Biology*Physics. 48(4). 1219–1226. 74 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hongkun Wang Breakdown of academic impact, for papers by Akihiro Hirakawa Breakdown of academic impact, for papers by Martin Jenkins Breakdown of academic impact, for papers by Jianchang Lin Breakdown of academic impact, for papers by Christophe Meille Breakdown of academic impact, for papers by Susan J. Robertson Breakdown of academic impact, for papers by Gwynn Ison Breakdown of academic impact, for papers by Joyce Cheng Breakdown of academic impact, for papers by Aracelis Z. Torres Breakdown of academic impact, for papers by Nadia Terranova
Rankless by CCL
2026